Exact Mass: 543.2104358
Exact Mass Matches: 543.2104358
Found 500 metabolites which its exact mass value is equals to given mass value 543.2104358
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Doxorubicin
Doxorubicin is only found in individuals that have used or taken this drug. It is antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of daunorubicin. [PubChem]Doxorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Doxorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D064
phosphoramidon
A dipeptide isolated from the cultures of Streptomyces tanashiensis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors KEIO_ID P122
Epirubicin
Epirubicin is only found in individuals that have used or taken this drug. It is an anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA. [PubChem]Epirubicin has antimitotic and cytotoxic activity. It inhibits nucleic acid (DNA and RNA) and protein synthesis through a number of proposed mechanisms of action: Epirubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. It also interferes with DNA replication and transcription by inhibiting DNA helicase activity. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Same as: D07901
Puromycin hydrochloride
Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis[1].
Carboxymethyl chitosan
Triferric doxorubicin
Phosphoramidon
Doxorubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
Lewis A trisaccharide methyl glycoside
C21H37NO15 (543.2163092000001)
Desalicetin-2-(4-Amino-2-hydroxybenzoyl)
C24H37N3O9S (543.2250392000001)
Epirubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent An anthracycline that is the 4-epi-isomer of doxorubicin. D004791 - Enzyme Inhibitors Same as: D07901
Ala His Met Trp
Ala His Trp Met
Ala Met His Trp
Ala Met Trp His
Ala Gln Tyr Tyr
Ala Trp His Met
Ala Trp Met His
Ala Tyr Gln Tyr
Ala Tyr Tyr Gln
Cys Cys Arg Tyr
Cys Cys Tyr Arg
Cys Glu His Arg
C20H33N9O7S (543.2223548000001)
Cys Glu Arg His
C20H33N9O7S (543.2223548000001)
Cys Phe Phe Gln
C26H33N5O6S (543.2151438000001)
Cys Phe Gln Phe
C26H33N5O6S (543.2151438000001)
Cys His Glu Arg
C20H33N9O7S (543.2223548000001)
Cys His Arg Glu
C20H33N9O7S (543.2223548000001)
Cys His Val Trp
Cys His Trp Val
Cys Lys Met Tyr
C23H37N5O6S2 (543.2185142000001)
Cys Lys Tyr Met
C23H37N5O6S2 (543.2185142000001)
Cys Met Lys Tyr
C23H37N5O6S2 (543.2185142000001)
Cys Met Gln Tyr
C22H33N5O7S2 (543.1821308000001)
Cys Met Tyr Lys
C23H37N5O6S2 (543.2185142000001)
Cys Met Tyr Gln
C22H33N5O7S2 (543.1821308000001)
Cys Gln Phe Phe
C26H33N5O6S (543.2151438000001)
Cys Gln Met Tyr
C22H33N5O7S2 (543.1821308000001)
Cys Gln Tyr Met
C22H33N5O7S2 (543.1821308000001)
Cys Arg Cys Tyr
Cys Arg Glu His
C20H33N9O7S (543.2223548000001)
Cys Arg His Glu
C20H33N9O7S (543.2223548000001)
Cys Arg Tyr Cys
Cys Val His Trp
Cys Val Trp His
Cys Trp His Val
Cys Trp Val His
Cys Tyr Cys Arg
Cys Tyr Lys Met
C23H37N5O6S2 (543.2185142000001)
Cys Tyr Met Lys
C23H37N5O6S2 (543.2185142000001)
Cys Tyr Met Gln
C22H33N5O7S2 (543.1821308000001)
Cys Tyr Gln Met
C22H33N5O7S2 (543.1821308000001)
Cys Tyr Arg Cys
Asp His Ser Trp
Asp His Trp Ser
Asp Ser His Trp
Asp Ser Trp His
Asp Trp His Ser
Asp Trp Ser His
Glu Cys His Arg
C20H33N9O7S (543.2223548000001)
Glu Cys Arg His
C20H33N9O7S (543.2223548000001)
Glu His Cys Arg
C20H33N9O7S (543.2223548000001)
Glu His Lys Met
Glu His Met Lys
Glu His Met Gln
Glu His Gln Met
Glu His Arg Cys
C20H33N9O7S (543.2223548000001)
Glu Lys His Met
Glu Lys Met His
Glu Met His Lys
Glu Met His Gln
Glu Met Lys His
Glu Met Gln His
Glu Gln His Met
Glu Gln Met His
Glu Arg Cys His
C20H33N9O7S (543.2223548000001)
Glu Arg His Cys
C20H33N9O7S (543.2223548000001)
Phe Cys Phe Gln
C26H33N5O6S (543.2151438000001)
Phe Cys Gln Phe
C26H33N5O6S (543.2151438000001)
Phe Phe Cys Gln
C26H33N5O6S (543.2151438000001)
Phe Phe Gln Cys
C26H33N5O6S (543.2151438000001)
Phe Asn Thr Tyr
Phe Asn Tyr Thr
Phe Gln Cys Phe
C26H33N5O6S (543.2151438000001)
Phe Gln Phe Cys
C26H33N5O6S (543.2151438000001)
Phe Gln Ser Tyr
Phe Gln Tyr Ser
Phe Ser Gln Tyr
Phe Ser Tyr Gln
Phe Thr Asn Tyr
Phe Thr Tyr Asn
Phe Tyr Asn Thr
Phe Tyr Gln Ser
Phe Tyr Ser Gln
Phe Tyr Thr Asn
His Ala Met Trp
His Ala Trp Met
His Cys Glu Arg
C20H33N9O7S (543.2223548000001)
His Cys Arg Glu
C20H33N9O7S (543.2223548000001)
His Cys Val Trp
His Cys Trp Val
His Asp Ser Trp
His Asp Trp Ser
His Glu Cys Arg
C20H33N9O7S (543.2223548000001)
His Glu Lys Met
His Glu Met Lys
His Glu Met Gln
His Glu Gln Met
His Glu Arg Cys
C20H33N9O7S (543.2223548000001)
His His His Asn
His His Asn His
His Lys Glu Met
His Lys Met Glu
His Met Ala Trp
His Met Glu Lys
His Met Glu Gln
His Met Lys Glu
His Met Gln Glu
His Met Trp Ala
His Asn His His
His Pro Gln Tyr
His Pro Tyr Gln
His Gln Glu Met
His Gln Met Glu
His Gln Pro Tyr
His Gln Tyr Pro
His Arg Cys Glu
C20H33N9O7S (543.2223548000001)
His Arg Glu Cys
C20H33N9O7S (543.2223548000001)
His Ser Asp Trp
His Ser Trp Asp
His Thr Thr Trp
His Thr Trp Thr
His Val Cys Trp
His Val Trp Cys
His Trp Ala Met
His Trp Cys Val
His Trp Asp Ser
His Trp Met Ala
His Trp Ser Asp
His Trp Thr Thr
His Trp Val Cys
His Tyr Pro Gln
His Tyr Gln Pro
Lys Cys Met Tyr
C23H37N5O6S2 (543.2185142000001)
Lys Cys Tyr Met
C23H37N5O6S2 (543.2185142000001)
Lys Glu His Met
Lys Glu Met His
Lys His Glu Met
Lys His Met Glu
Lys Met Cys Tyr
C23H37N5O6S2 (543.2185142000001)
Lys Met Glu His
Lys Met His Glu
Lys Met Tyr Cys
C23H37N5O6S2 (543.2185142000001)
Lys Tyr Cys Met
C23H37N5O6S2 (543.2185142000001)
Lys Tyr Met Cys
C23H37N5O6S2 (543.2185142000001)
Met Ala His Trp
Met Ala Trp His
Met Cys Lys Tyr
C23H37N5O6S2 (543.2185142000001)
Met Cys Gln Tyr
C22H33N5O7S2 (543.1821308000001)
Met Cys Tyr Lys
C23H37N5O6S2 (543.2185142000001)
Met Cys Tyr Gln
C22H33N5O7S2 (543.1821308000001)
Met Glu His Lys
Met Glu His Gln
Met Glu Gln His
Met His Ala Trp
Met His Glu Gln
Met His Gln Glu
Met His Trp Ala
Met Lys Cys Tyr
C23H37N5O6S2 (543.2185142000001)
Met Lys Tyr Cys
C23H37N5O6S2 (543.2185142000001)
Met Gln Cys Tyr
C22H33N5O7S2 (543.1821308000001)
Met Gln Glu His
Met Gln His Glu
Met Gln Tyr Cys
C22H33N5O7S2 (543.1821308000001)
Met Trp Ala His
Met Trp His Ala
Met Tyr Cys Lys
C23H37N5O6S2 (543.2185142000001)
Met Tyr Cys Gln
C22H33N5O7S2 (543.1821308000001)
Met Tyr Lys Cys
C23H37N5O6S2 (543.2185142000001)
Met Tyr Gln Cys
C22H33N5O7S2 (543.1821308000001)
Asn Phe Thr Tyr
Asn Phe Tyr Thr
Asn His His His
Asn Pro Gln Trp
Asn Pro Trp Gln
Asn Gln Pro Trp
Asn Gln Trp Pro
Asn Thr Phe Tyr
Asn Thr Tyr Phe
Asn Trp Pro Gln
Asn Trp Gln Pro
Asn Tyr Phe Thr
Asn Tyr Thr Phe
Pro His Gln Tyr
Pro His Tyr Gln
Pro Asn Gln Trp
Pro Asn Trp Gln
Pro Gln His Tyr
Pro Gln Asn Trp
Pro Gln Trp Asn
Pro Gln Tyr His
Pro Trp Asn Gln
Pro Trp Gln Asn
Pro Tyr His Gln
Pro Tyr Gln His
Gln Ala Tyr Tyr
Gln Cys Phe Phe
C26H33N5O6S (543.2151438000001)
Gln Cys Met Tyr
C22H33N5O7S2 (543.1821308000001)
Gln Cys Tyr Met
C22H33N5O7S2 (543.1821308000001)
Gln Glu His Met
Gln Glu Met His
Gln Phe Cys Phe
C26H33N5O6S (543.2151438000001)
Gln Phe Phe Cys
C26H33N5O6S (543.2151438000001)
Gln Phe Ser Tyr
Gln Phe Tyr Ser
Gln His Glu Met
Gln His Met Glu
Gln His Pro Tyr
Gln His Tyr Pro
Gln Met Cys Tyr
C22H33N5O7S2 (543.1821308000001)
Gln Met Glu His
Gln Met His Glu
Gln Met Tyr Cys
C22H33N5O7S2 (543.1821308000001)
Gln Asn Pro Trp
Gln Asn Trp Pro
Gln Pro His Tyr
Gln Pro Asn Trp
Gln Pro Trp Asn
Gln Pro Tyr His
Gln Ser Phe Tyr
Gln Ser Tyr Phe
Gln Trp Asn Pro
Gln Trp Pro Asn
Gln Tyr Ala Tyr
Gln Tyr Cys Met
C22H33N5O7S2 (543.1821308000001)
Gln Tyr Phe Ser
Gln Tyr His Pro
Gln Tyr Met Cys
C22H33N5O7S2 (543.1821308000001)
Gln Tyr Pro His
Gln Tyr Ser Phe
Gln Tyr Tyr Ala
Arg Cys Cys Tyr
Arg Cys Glu His
C20H33N9O7S (543.2223548000001)
Arg Cys His Glu
C20H33N9O7S (543.2223548000001)
Arg Cys Tyr Cys
Arg Glu Cys His
C20H33N9O7S (543.2223548000001)
Arg Glu His Cys
C20H33N9O7S (543.2223548000001)
Arg His Cys Glu
C20H33N9O7S (543.2223548000001)
Arg His Glu Cys
C20H33N9O7S (543.2223548000001)
Arg Tyr Cys Cys
Ser Asp His Trp
Ser Asp Trp His
Ser Phe Gln Tyr
Ser Phe Tyr Gln
Ser His Asp Trp
Ser His Trp Asp
Ser Gln Phe Tyr
Ser Gln Tyr Phe
Ser Trp Asp His
Ser Trp His Asp
Ser Tyr Phe Gln
Ser Tyr Gln Phe
Thr Phe Asn Tyr
Thr Phe Tyr Asn
Thr His Thr Trp
Thr His Trp Thr
Thr Asn Phe Tyr
Thr Asn Tyr Phe
Thr Thr His Trp
Thr Thr Trp His
Thr Trp His Thr
Thr Trp Thr His
Thr Tyr Phe Asn
Thr Tyr Asn Phe
Val Cys His Trp
Val Cys Trp His
Val His Cys Trp
Val His Trp Cys
Val Trp Cys His
Val Trp His Cys
Trp Ala His Met
Trp Ala Met His
Trp Cys His Val
Trp Cys Val His
Trp Asp His Ser
Trp Asp Ser His
Trp His Ala Met
Trp His Cys Val
Trp His Asp Ser
Trp His Met Ala
Trp His Ser Asp
Trp His Thr Thr
Trp His Val Cys
Trp Met Ala His
Trp Met His Ala
Trp Asn Pro Gln
Trp Asn Gln Pro
Trp Pro Asn Gln
Trp Pro Gln Asn
Trp Gln Asn Pro
Trp Gln Pro Asn
Trp Ser Asp His
Trp Ser His Asp
Trp Thr His Thr
Trp Thr Thr His
Trp Val Cys His
Trp Val His Cys
Tyr Ala Gln Tyr
Tyr Ala Tyr Gln
Tyr Cys Cys Arg
Tyr Cys Lys Met
C23H37N5O6S2 (543.2185142000001)
Tyr Cys Met Lys
C23H37N5O6S2 (543.2185142000001)
Tyr Cys Met Gln
C22H33N5O7S2 (543.1821308000001)
Tyr Cys Gln Met
C22H33N5O7S2 (543.1821308000001)
Tyr Cys Arg Cys
Tyr Phe Asn Thr
Tyr Phe Gln Ser
Tyr Phe Ser Gln
Tyr Phe Thr Asn
Tyr His Pro Gln
Tyr His Gln Pro
Tyr Lys Cys Met
C23H37N5O6S2 (543.2185142000001)
Tyr Lys Met Cys
C23H37N5O6S2 (543.2185142000001)
Tyr Met Cys Lys
C23H37N5O6S2 (543.2185142000001)
Tyr Met Cys Gln
C22H33N5O7S2 (543.1821308000001)
Tyr Met Lys Cys
C23H37N5O6S2 (543.2185142000001)
Tyr Met Gln Cys
C22H33N5O7S2 (543.1821308000001)
Tyr Asn Phe Thr
Tyr Asn Thr Phe
Tyr Pro His Gln
Tyr Pro Gln His
Tyr Gln Ala Tyr
Tyr Gln Cys Met
C22H33N5O7S2 (543.1821308000001)
Tyr Gln Phe Ser
Tyr Gln His Pro
Tyr Gln Met Cys
C22H33N5O7S2 (543.1821308000001)
Tyr Gln Pro His
Tyr Gln Ser Phe
Tyr Gln Tyr Ala
Tyr Arg Cys Cys
Tyr Ser Phe Gln
Tyr Ser Gln Phe
Tyr Thr Phe Asn
Tyr Thr Asn Phe
Tyr Tyr Ala Gln
Tyr Tyr Gln Ala
Puromycin dihydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis[1].
4-METHOXYPHENYL 3-O-ALLYL-4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-BETA-D-GLUCOPYRANOSIDE
GSK461364
2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethanol Fumarate
2-{4-[(2S)-2-[({[(1S)-1-Carboxy-2-phenylethyl]amino}carbonyl)amino]-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid
C27H33N3O9 (543.2216688000001)
Sulfamethoxazole; Trimethoprim
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EE - Combinations of sulfonamides and trimethoprim, incl. derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Phosphoramidon
(1R,2R,4S)-4-[(3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2S)-2-[[(2R)-2-[[hydroxy-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
(7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-OMe
C21H37NO15 (543.2163092000001)
(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
6-(4-Benzylpiperazine-1-carbonyl)-2-[3-(trifluoromethyl)phenyl]benzo[de]isoquinoline-1,3-dione
2-O-methyl-alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranose
C21H37NO15 (543.2163092000001)
2-O-methyl-alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranose
C21H37NO15 (543.2163092000001)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
(2S)-2-[(4S,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyridinyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(2S)-2-[(4R,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
1-[(1R,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
N-[[(2R,3S)-8-(3-hydroxyhex-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,4-dimethylbenzenesulfonamide
(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C31H33N3O6 (543.2369238000001)
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
(2S)-2-[(4R,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
1-[(1S,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
1-[(1R,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C26H33N5O6S (543.2151438000001)
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide
C31H33N3O6 (543.2369238000001)
(2R)-2-[(4S,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
1-[(1S,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
1-[(1R,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
1-[(1S,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
1-[(1S,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
C31H33N3O6 (543.2369238000001)
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(1-oxo-2-pyridin-4-ylethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(1-oxo-2-pyridin-4-ylethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyridinyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(7R,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
10-Carboxy-13-deoxycarminomycin
An anthracycline antibiotic that is 13-deoxycarminomycin substituted at position 10 by a carboxy group.
7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
10-carboxy-13-deoxycarminomycin zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the primary amino group of 10-carboxy-13-deoxycarminomycin; major species at pH 7.3.
5'-Guanidinonaltrindole (hydrochloride)
5'-Guanidinonaltrindole (5'-GNTI) hydrochloride is a highly selective and potent κ-opioid receptor antagonist with a Ki of 0.18 nM for human κ-opioid receptor[1].
1-hydroxy-3,5,6-trimethoxy-4-[(1r)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
(2s,3s,4r)-4-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6-imino-3-methoxy-2-methyl-3,4-dihydrotetracene-1,11-dione
(7r,8r,10s)-7-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,8,10,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
1,6-dihydroxy-3,5-dimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10-methylacridin-9-one
4-{1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl}-1-methoxy-1,2-dimethyl-4h-pyrazino[2,1-b]quinazoline-3,6-dione
C29H29N5O6 (543.2117734000001)
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
1-hydroxy-3,5,6-trimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
(7r,8r)-7-{[(2s,4r,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
4-[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)oxy]-2,5,7-trihydroxy-6-imino-3-methoxy-2-methyl-3,4-dihydrotetracene-1,11-dione
(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy([(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy)phosphoryl]amino}-4-methylpentylidene]amino}-3-(1h-indol-3-yl)propanoic acid
(7r,8s,10r)-7-{[(2r,4r,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,10-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(8s,9s,10r)-12-amino-10-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-9-methoxy-8-methyl-9,10-dihydrotetracene-1,5,7-trione
10-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(7r,8r,10s)-10-{[(2r,4s,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,7,8-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(2r)-n-[(1r,2r)-1-[(2s,3r,4s,5s,6r)-6-{[2-(4-amino-2-hydroxybenzoyloxy)ethyl]sulfanyl}-3,4,5-trihydroxyoxan-2-yl]-2-methoxypropyl]-1-methylpyrrolidine-2-carboximidic acid
C24H37N3O9S (543.2250392000001)
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-(6-{[(2e)-3-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl]amino}purin-9-yl)oxane-3,4,5-triol
7-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,4,6,8,10-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(1r,4r)-4-[(9'r,9'as)-1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl]-1-methoxy-1,2-dimethyl-4h-pyrazino[2,1-b]quinazoline-3,6-dione
C29H29N5O6 (543.2117734000001)
methyl 4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2,5,7,12-tetrahydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(6s,8r,11ar,12r,13s,14r,14ar,15r,17ar)-6,12,13,17-tetrahydroxy-15-[(4-methoxyphenyl)methyl]-6,8,13,14-tetramethyl-8h,9h,11ah,12h,14h,14ah,15h-1,3-dioxacyclotrideca[4,5-d]isoindole-2,7-dione
1-hydroxy-3,5,6-trimethoxy-4-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
1-hydroxy-3,5,6-trimethoxy-2-[(1r)-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-en-1-yl]-10h-acridin-9-one
n-[1-(6-{[2-(4-amino-2-hydroxybenzoyloxy)ethyl]sulfanyl}-3,4,5-trihydroxyoxan-2-yl)-2-methoxypropyl]-1-methylpyrrolidine-2-carboximidic acid
C24H37N3O9S (543.2250392000001)